Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report

Haematologica. 2019 Sep;104(9):e432-e433. doi: 10.3324/haematol.2018.214635. Epub 2019 Apr 11.

Authors

Katrine F Iversen¹, Paw C Holdgaard², Birgitte Preiss³, Charlotte G Nyvold⁴, Torben Plesner⁵

Affiliations

¹ Department of Hematology, Vejle Hospital and University of Southern Denmark, Vejle katrine.fladeland.iversen@rsyd.dk.
² Department of Nuclear Medicine, Vejle Hospital, Vejle.
³ Department of Pathology, Odense University Hospital.
⁴ Haematology-Pathology Research Laboratory, Department of Hematology, Odense University Hospital, Odense, Denmark.
⁵ Department of Hematology, Vejle Hospital and University of Southern Denmark, Vejle.

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / pharmacology*
Biopsy
Cyanosis
Dendritic Cells / cytology*
Dendritic Cells / drug effects*
Humans
Immunoglobulin G / pharmacology
Male
Mutation
Positron Emission Tomography Computed Tomography
Prognosis
Retrospective Studies
Skin Neoplasms / diagnostic imaging
Skin Neoplasms / drug therapy*
Treatment Outcome

Substances

Antibodies, Monoclonal
Immunoglobulin G
daratumumab